About us
Founded in 2004, DIURNAL®, a NEUROCRINE BIOSCIENCES® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency.
- Website
-
https://www.diurnal.com/
External link for Diurnal
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held